Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Raymond Sackler

American physician

Raymond Sackler    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Raymond Sackler was an American physician, billionaire entrepreneur, and philanthropist. Raymond Sackler was, together with his brother Mortimer Sackler, owner of Purdue Pharma, the developer of OxyContin.

0
shares
ShareTweetSavePostSend
 

Judge Orders Pause in Opioid Litigation Against Purdue Pharma and Sacklers

The stay is only until Nov. 6. During that time, the parties must negotiate a plan for disclosing the details of the Sacklers’ wealth and Purdue’s role in the opioid epidemic.
NYTimes.com - Published

Sacklers reaped up to $13 billion from OxyContin maker, U.S. states say

OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company's controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and..
Reuters - Published

Purdue Says Sacklers May Walk From Opioid Deal if Judge Does Not Block Cases

The company said the cost of fighting lawsuits brought by states could jeopardize its owners’ ability to contribute $3 billion to a national opioids settlement.
NYTimes.com - Published

Purdue Pharma seeks to halt opioid suits against company, Sacklers

OxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to halt for roughly nine months more than 2,600 lawsuits alleging the company and its controlling Sackler family helped fuel..
Reuters - Published

OxyContin maker Purdue Pharma files for bankruptcy

oxycontin maker purdue pharma files for bankruptcy
Purdue Pharma filed for bankruptcy with a more than $10 billion (Dh36.7bn) plan to settle claims that it fuelled the US opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller...
WorldNews - Published

Sackler family could pay billions to settle opioid lawsuits

The billionaire Sackler family may be willing to pay up, to settle thousands of lawsuits stemming from the opioid crisis. The proposed settlement comes amid speculation that the family's company,..
CBS News - Published

Sacklers vs. States: Settlement Talks Stumble Over Foreign Business

The Sackler family is willing to give up Purdue Pharma to settle all claims related to the opioid crisis, but is resisting a quick sale of its overseas drug company.
NYTimes.com - Published

Where did the Sacklers shift cash from their opioid maker?

A web of trusts and companies, some located in tax havens, may complicate efforts to reach a financial settlement
CBS News - Published

Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The company is in discussions to resolve thousands of lawsuits. Participants in the talks value the plan at between $10 billion and $12 billion.
NYTimes.com - Published

Purdue, Sacklers offer bankruptcy, $10-12 billion for opioid settlement: Report

purdue, sacklers offer bankruptcy, $10-12 billion for opioid settlement: report
OxyContin-maker Purdue Pharma and its owners, the Sackler family, offered a $10 billion to $12 billion deal to settle around 2,000...
WorldNews - Published

Purdue Pharma 'offers up to $12bn' to settle opioid cases

The firm, owned by the wealthy Sackler family, is facing 2,000 claims over its painkiller OxyContin.
BBC News - Published

Israel, Sacklers, ‘Black Woodstock’: Your Thursday Evening Briefing

Here’s what you need to know at the end of the day.
NYTimes.com - Published

Louvre museum removes name of Sackler family linked to opioid crisis

louvre museum removes name of sackler family linked to opioid crisis
The Louvre museum in Paris has ended its public association with the Sackler family, which has been tied to the opioid crisis in the United States. According to The New York Times, a plaque dedicated..
WorldNews - Published

You Might Like


Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.